Kensey Nash (KNSY) announced its earnings results on Thursday. The company reported $0.51 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.46 by $0.05. The company’s quarterly revenue was up 32.2% on a year-over-year basis.
On a related note, analysts at Zacks Investment Research downgraded shares of Kensey Nash from a “neutral” rating to an “underperform” rating in a research note to investors on Thursday, December 22nd. Analysts at Jefferies Group (NYSE: JEF) reiterated a “hold” rating on shares of Kensey Nash in a research note to investors on Monday, December 19th. Also, analysts at Jefferies Group (NYSE: JEF) cut their price target on shares of Kensey Nash to $21.00 in a research note to investors on Friday, December 16th.
Shares of Kensey Nash (KNSY) opened at 23.89 on Thursday. Kensey Nash (KNSY) has a 52 week low of $18.17 and a 52 week high of $29.39. The stock’s 50-day moving average is $21.16 and its 200-day moving average is $24.83. The company has a market cap of $206.5 million and a P/E ratio of 419.12.
Kensey Nash Corporation is a medical device company primarily focused in the field of regenerative medicine, which is the application of devices, materials and other therapies to help repair damaged or diseased tissues. The Company has a range of products, which are sold through strategic partners in multiple large medical markets, including cardiology, orthopaedic, sports medicine, spinal and general surgery. It also has an ongoing development and manufacturing program for products in the endovascular market. During the fiscal year ended June 30, 2010 (fiscal 2010), the Company manufactured and sold over 4.5 million resorbable product units representing approximately 230 commercialized products, to strategic partners and customers. The Company’s Optrix process allows it to manufacture extracellular matrix (ECM) products.
Stay on top of analysts' coverage with our daily email newsletter that provides a concise list of analysts' upgrades, analysts' downgrades and analysts' price target changes for each day. Click here to register.